Additionally, in our analysis of 46 stages I/II and 17 stages III/IV primary lung carcinomas (Table 2), approximately 61% of stages I/II and 76% of stages III/IV carcinomas are CNTN-1-positive (Figure 3B), indicating a role of CNTN-1 in lung cancer progression. This evidence concerns the gene CNTN1 and lung carcinoma.